Positioning no disclosures inside 60 days, left as found
Options no verdict drawn today, left as found
Ethical does not pass the values gate
Price28.73 USD
Fair value19.24
Ethical score70.0/100
Our investment reviews on this name
2026-10-29Read Markup28.86-0.5% to today Markdown gives way to Markup first Markup read since July
2026-08-26Read Markdown29.62-3.0% to today ✓Markup gives way to Markdown
2026-07-02Read Markup30.96-7.2% to today First review on file: Markup
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Curbline Properties Corp. holds its Markup at $28.73. Consolidating, no directional conviction, held for 463 days.
As held on the ledger · 2026-10-29
Phase
Markup
Quantitative state
Consolidating, no directional conviction, held for 463 days
Price at the screen
$28.73
Valuation
96.11 trailing · 72.08 forward price to earnings
Values screen
FAIL· score 70.0
Beta
0.62
The Workings
Five Screens, Shown in Full
Does not pass. Revenue purity
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
17.14%
Below 33%
Interest-bearing debt is just 17.1% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
12.64%
Below 49%
Money owed to the company is 12.6% of assets, under the 49% limit.
Pass
Revenue purity
10.15%
Below 5%
10.1% of revenue comes from non-compliant sources, over the 5% line.
Fail
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
Curbline Properties clears the business-activity screen, and its debt is inside the line. Where it falls short is income purity: around 10% of its income right now is non-operating interest income, against a roughly 5% ceiling, so it does not pass. That reflects what it earns today, not the business itself, and it could clear the screen if its operating revenue grows and the interest share falls.
Read as at 2026-10-30. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when CURB's ethical verdict changes
Today CURB does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
Fair value range in USD, drawn from the 2026-10-29 screen. The gold marker is the market price at the same screen. The price runs 33.0% above the base estimate.
Third-party analyst targets: 9 covering, consensus Buy. The average target sits +13% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-29 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Corner shop REIT priced like a growth rocket
Every driver stopping for coffee or a quick errand at a suburban curbline plaza pays rent to Curbline Properties. Revenue is rising 50% and the ethical screen clears, yet shares sit at $31.64 against our fair value of just $16.88. Forward earnings trade at 287 times, a multiple that assumes flawless execution the numbers do not support.
We pass. Profit margins sit at 16% and return on equity is a thin 2%, leaving little cushion if footfall slows. An unknown moat and retail exposure to shifting consumer habits add further distance from the current quote.
Consensus targets hover near $32, but those views ignore the gap between price and value. The low return profile and stretched multiple point to downside rather than safety. Analysis, not advice.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
CURB trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-10-29Markup · changed$28.86+7.2%Entry 16
The framework has shifted from markdown to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 7.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 7% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 33%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (9 analysts) rates it buy, with a mean price target of $31.
2026-10-22Markdown$26.91+1.3%Entry 15
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 1.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 33%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (9 analysts) rates it buy, with a mean price target of $31. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-21Markdown$26.56+0.0%Entry 14
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 33%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (9 analysts) rates it buy, with a mean price target of $31. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-20Markdown$26.56+0.0%Entry 13
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 33%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (9 analysts) rates it buy, with a mean price target of $31. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-19Markdown$26.56+0.0%Entry 12
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 33%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (9 analysts) rates it buy, with a mean price target of $31. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-18Markdown$26.56+0.0%Entry 11
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 19% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 33%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (9 analysts) rates it buy, with a mean price target of $31. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-17Markdown$26.56+0.0%Entry 10
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 19% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 33%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (9 analysts) rates it buy, with a mean price target of $31. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-16Markdown$26.56-1.7%Entry 9
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 1.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 19% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 33%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (9 analysts) rates it buy, with a mean price target of $31. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-15Markdown$27.01+0.0%Entry 8
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 19% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 33%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (9 analysts) rates it buy, with a mean price target of $31. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-14Markdown$27.01-5.8%Entry 7
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 5.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 19% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 33%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (9 analysts) rates it buy, with a mean price target of $31.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.